Lannett Co Inc (LCI): Price and Financial Metrics

Lannett Co Inc (LCI)

Today's Latest Price: $8.75 USD

0.20 (-2.23%)

Updated Jan 27 6:30pm

Add LCI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

LCI Stock Summary

  • LCI's current price/earnings ratio is 116.04, which is higher than 94.44% of US stocks with positive earnings.
  • Over the past twelve months, LCI has reported earnings growth of -136.1%, putting it ahead of just 10.26% of US stocks in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for LCI comes in at 32.17% -- higher than that of 93.28% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Lannett Co Inc are TEAR, COHR, SPRT, MKSI, and JRJC.
  • Visit LCI's SEC page to see the company's official filings. To visit the company's web site, go to
LCI Daily Price Range
LCI 52-Week Price Range

LCI Stock Price Chart More Charts

LCI Price/Volume Stats

Current price $8.75 52-week high $15.52
Prev. close $8.95 52-week low $5.16
Day low $8.61 Volume 707,024
Day high $8.91 Avg. volume 936,065
50-day MA $8.92 Dividend yield N/A
200-day MA $8.49 Market Cap 352.86M

Lannett Co Inc (LCI) Company Bio

Lannett Company develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.

LCI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$8.75$171.92 1654%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Lannett Co Inc. To summarize, we found that Lannett Co Inc ranked in the 92th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for Lannett Co Inc ended up being:

  • 34% of the company's capital comes from equity, which is greater than only 10.86% of stocks in our cash flow based forecasting set.
  • The business' balance sheet suggests that 66% of the company's capital is sourced from debt; this is greater than 89.1% of the free cash flow producing stocks we're observing.
  • The weighted average cost of capital for the company is 12. This value is greater than 86.16% stocks in the Healthcare sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

SUPN, EGRX, PTN, ARNA, and DPLO can be thought of as valuation peers to LCI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

LCI Latest News Stream

Event/Time News Detail
Loading, please wait...

LCI Latest Social Stream

Loading social stream, please wait...

View Full LCI Social Stream

LCI Price Returns

1-mo 1.51%
3-mo -29.03%
6-mo 23.76%
1-year 5.55%
3-year -55.36%
5-year -82.39%
YTD -0.79%
2019 77.82%
2018 -78.62%
2017 5.22%
2016 -45.04%
2015 -6.44%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6472 seconds.